Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Vaspin in type 2 diabetes in relation to atherosclerosis

The Egyptian Journal of Internal Medicine volume 26, pages 130–136 (2014)Cite this article

Abstract

Background

Vaspin is a novel adipocytokine with insulin-sensitizing effects. However, it is not known whether a correlation exists between human vaspin serum levels and markers of insulin sensitivity and glucose or lipid metabolism.

Aim of the work

To determine whether there is an association between serum vaspin levels (a novel adipocytokine with insulin-sensitizing effects), type 2 diabetes mellitus (T2D) and atherosclerosis.

Patients and methods

The study included 40 patients with T2D divided into 20 without hypertension (group 1), 20 with hypertension (group 2) and 15 age-matched and sex-matched healthy control participants (group 3). The serum vaspin level was determined by enzyme-linked immunosorbent assay. Its level was compared between both diabetic patients and controls, and between diabetic patients without hypertension and those with hypertension. All participants were subjected to an imaging procedure in the form of carotid Doppler to measure the intima — media thickness as an early marker of atherosclerosis.

Results

The serum vaspin level was significantly higher in diabetic patients compared with control participants. There was significant increase in the left carotid intima–media thickness in diabetic patients with hypertension and without hypertension compared with control participants. There was a significant positive correlation between the serum vaspin level and the BMI in diabetic patients with hypertension, a significant negative correlation between the serum vaspin level and the duration of diabetes and a significant negative correlation between the serum vaspin level and HDL in diabetic patients without hypertension.

Conclusion

There was a significantly high level of serum vaspin in T2D patients. Serum vaspin was shown to be significantly lower in T2D patients with a longer duration of illness. An increased carotid intima–media thickness in diabetic patients was not related to the vaspin level, denoting an underlying combining factor for atherosclerosis in diabetic patients other than vaspin.

References

  1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87:4–14.

    Article  CAS  PubMed  Google Scholar 

  2. Stas SN, El Atat FA, Sowers JR. Pathogenesis of hypertension in diabetes. Rev Endocr Metab Disord 2004; 5:221–225.

    Article  CAS  PubMed  Google Scholar 

  3. Maiti R, Agrawal NK. Atherosclerosis in diabetes mellitus: role of inflammation. Indian J Med Sci 2007; 61:292–306.

    Article  PubMed  Google Scholar 

  4. Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010; 21:660–667.

    Article  CAS  PubMed  Google Scholar 

  5. Lago F, Dieguez C, Gómez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007; 18:313–325.

    Article  CAS  PubMed  Google Scholar 

  6. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992; 41:1422–1428.

    CAS  PubMed  Google Scholar 

  7. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes care 2003; 26:5–20.

    Article  Google Scholar 

  8. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499–502.

    Article  Google Scholar 

  9. Inoue J, Wada J, Teshigawara S, Hida K, Nakatsuka A, Takatori Y, et al. The serum vaspin levels are reduced in Japanese chronic hemodialysis patients. BMC Nephrol 2012; 313:163.

    Article  Google Scholar 

  10. Ye Y, Hou XH, Pan XP, Lu JX, Jia WP. Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes. Chin Med J (Engl) 2009; 122:2530–2533.

    CAS  Google Scholar 

  11. El-Mesallamy HO, Kassem DH, El-Demerdash E, Amin AI. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 2011; 60:63–70.

    Article  CAS  PubMed  Google Scholar 

  12. Domaa AM, El-Bagori NN, El- Sayd MM. The clinical significance of vaspin and chemerin in diabetic obese Libyan patients. Curr Sci Int 2012; 2:1–5.

    Google Scholar 

  13. Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, Song ES, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008; 57:372–377.

    Article  CAS  PubMed  Google Scholar 

  14. Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J, Bluher M, et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008; 93:247–251.

    Article  CAS  PubMed  Google Scholar 

  15. Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009; 160:65–70.

    Article  CAS  PubMed  Google Scholar 

  16. Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schon MR,et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006; 339:430–436.

    Article  PubMed  Google Scholar 

  17. Feng RN, Wang C, Sun CH, Guo FG, Zhao C, Li Y. Vaspin in newly and previously diagnosed Chinese type 2 diabetic females: a case–control study. Asian Biomed 2011; 5:525–529.

    Article  CAS  Google Scholar 

  18. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 1996; 124:548–556.

    Article  CAS  PubMed  Google Scholar 

  19. O’Leary DH, Polak JF, Kronmal RA, Savage PJ, Borhani NO, Kittner SJ, et al. Thickening of the carotid wall: a marker for atherosclerosis in the elderly?. Stroke 1996; 27:224–231.

    Article  PubMed  Google Scholar 

  20. Li Z, Ma C, Li L, Pan X, Chen L. Vaspin serum concentration in patients with type 2 diabetes and carotid plaque. J Int Med Res 2012; 40:1670–1676.

    Article  CAS  PubMed  Google Scholar 

  21. Kadoglou NP, Gkontopoulos A, Kapelouzou A, Fotiadis G, Theofilogiannakos EK, Kottas G, et al. Serum levels of vaspin and visfatin in patients with coronary artery disease — Kozani study. Clin Chim Acta 2011; 412:48–52.

    Article  CAS  PubMed  Google Scholar 

  22. Kobat MA, Celik A, Balin M, Altas Y, Baydas A, Bulut M, et al. The investigation of serum vaspin level in atherosclerotic coronary artery disease. J Clin Med Res 2012; 4:110–113.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Al Kasr Al Ainy Hospital, Faculty of Medicine, Cairo University, Egypt

    Nehal H. El-Said & Noha A. Sedik MD

  2. Department of Clinical and Chemical Pathology, National Research Center, Cairo, Egypt

    Nagwa A. Mohamed

Authors
  1. Nehal H. El-Said
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noha A. Sedik MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nagwa A. Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noha A. Sedik MD.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El-Said, N.H., Sedik, N.A. & Mohamed, N.A. Vaspin in type 2 diabetes in relation to atherosclerosis. Egypt J Intern Med 26, 130–136 (2014). https://doi.org/10.4103/1110-7782.145314

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1110-7782.145314

Keywords